Healthcare

Island Pharmaceuticals Limited (ASX:ILA) develops clinical-stage antiviral treatments for infectious diseases, using a drug-repurposing approach and prior research to inform development. Its two programs address different viral threats: Galidesivir is being advanced for serious RNA-virus infections, including Marburg, while ISLA-101 is being investigated for …

The technology used by Immuron Limited (ASX:IMC) begins with bovine colostrum containing antibodies directed towards selected biological targets. These immunoglobulins are intended to act within the gastrointestinal tract. The approach differs from therapies designed for systemic absorption because the site of action is the …

In March 2026, an independent data monitoring committee recommended that the TACTI-004 Phase III study in first-line non-small cell lung cancer be discontinued after a planned interim futility analysis. The recommendation followed a review of available efficacy and safety data. Immutep Limited (ASX:IMM) halted …

Imricor Medical Systems, Inc. (ASX:IMR) develops magnetic resonance (MR)-compatible devices and systems for cardiac interventions performed under MRI guidance. Its technology is intended to let clinicians see soft tissue and catheter position during procedures without X-ray fluoroscopy. During 2026, the company reported US regulatory …

Glaucoma treatment often seeks to reduce intraocular pressure, an important factor in managing the condition. Canaloplasty addresses the eye’s conventional drainage system rather than introducing an implanted bypass. Nova Eye Medical (ASX:EYE) describes its approach as 360-degree catheterisation and pressurised viscodilation of Schlemm’s canal …

Firebrick Pharma Limited (ASX:FRE) develops and commercialises povidone-iodine-based consumer healthcare products, with Nasodine Nasal Spray at the centre of its portfolio. The company also markets Nasodine Throat Spray and works with international distribution partners. Its 2026 activities have combined product launches, overseas registration work …

Cerebrospinal fluid helps protect the brain and spinal cord, while its production and drainage contribute to pressure regulation inside the skull. The choroid plexus is involved in producing this fluid. Invex’s development strategy investigates whether exenatide, a GLP-1 receptor agonist already used in diabetes …